Jpmorgan Chase & CO DEXCOM INC Transaction History

Jpmorgan Chase & CO

11,738,000

Previous 14,648,000 19.87%

Previous $0 NaN%

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	N/A	-2,910,000 Reduced 19.87%	11,738,000 $0
Q2 2024 Aug 12, 2024	BUY	N/A	699,000 Added 5.01%	14,648,000 $0
Q1 2024 May 10, 2024	BUY	N/A	830,000 Added 6.33%	13,949,000 $0
Q4 2023 Feb 12, 2024	SELL	N/A	-21,953,000 Reduced 62.59%	13,119,000 $0
Q3 2023 Nov 14, 2023	BUY	N/A	24,185,000 Added 222.15%	35,072,000 $0
Q2 2023 Aug 11, 2023	BUY	N/A	1,656,000 Added 17.94%	10,887,000 $0
Q1 2023 May 11, 2023	BUY	N/A	2,813,000 Added 43.83%	9,231,000 $0
Q4 2022 Feb 13, 2023	SELL	N/A	-2,628,000 Reduced 29.05%	6,418,000 $6.93 Million
Q3 2022 Nov 14, 2022	SELL	N/A	-6,967,000 Reduced 43.51%	9,046,000 $8.66 Million
Q2 2022 Aug 11, 2022	SELL	N/A	-11,520,000 Reduced 41.84%	16,013,000 $14.7 Million
Q1 2022 May 11, 2022	SELL	N/A	-6,568,000 Reduced 19.26%	27,533,000 $31.7 Million
Q4 2021 Feb 10, 2022	SELL	N/A	-12,548,000 Reduced 26.9%	34,101,000 $41.7 Million
Q3 2021 Nov 12, 2021	BUY	N/A	46,649,000 New	46,649,000 $55.3 Million

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.